Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation.

MLA

Taub, Mary, et al. “Renal Oncometabolite L-2-Hydroxyglutarate Imposes a Block in Kidney Tubulogenesis: Evidence for an Epigenetic Basis for the L-2HG-Induced Impairment of Differentiation.” Frontiers in Endocrinology, vol. 13, Sept. 2022, pp. 1–20. EBSCOhost, https://doi.org/10.3389/fendo.2022.932286.

APA

Taub, M., Mahmoudzadeh, N. H., Tennessen, J. M., & Sudarshan, S. (2022). Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation. Frontiers in Endocrinology, 13, 1–20. https://doi.org/10.3389/fendo.2022.932286

Chicago

Taub, Mary, Nader H. Mahmoudzadeh, Jason M. Tennessen, and Sunil Sudarshan. 2022. “Renal Oncometabolite L-2-Hydroxyglutarate Imposes a Block in Kidney Tubulogenesis: Evidence for an Epigenetic Basis for the L-2HG-Induced Impairment of Differentiation.” Frontiers in Endocrinology 13 (September): 1–20. doi:10.3389/fendo.2022.932286.